SCCM: Hypothermia No Benefit After Pediatric Cardiac Arrest

This article originally appeared here.
Share this content:
SCCM: Hypothermia No Benefit After Pediatric Cardiac Arrest
SCCM: Hypothermia No Benefit After Pediatric Cardiac Arrest

WEDNESDAY, Jan. 25, 2017 (HealthDay News) -- Therapeutic hypothermia is not associated with significant benefit in survival with favorable functional outcome among comatose children who survive in-hospital cardiac arrest, according to a study published online Jan. 24 in the New England Journal of Medicine. The research was published to coincide with the annual Society of Critical Medicine's Critical Care Congress, held from Jan 21 to 25, Honolulu.

Frank Moler, M.D., from the University of Michigan Health System in Ann Arbor, and colleagues conducted a trial at 37 children's hospitals to compare two temperature interventions in children with in-hospital cardiac arrest. Comatose children older than 48 hours and younger than 18 years were randomized to therapeutic hypothermia or therapeutic normothermia.

After randomization of 329 patients, the trial was terminated because of futility. Among the 257 patients with a Vineland Adaptive Behavior Scales, second edition (VABS-II) score of at least 70 before cardiac arrest and who could be evaluated, the researchers observed no significant difference between the hypothermia and normothermia groups in terms of the primary efficacy outcome (survival at 12 months after cardiac arrest with a score of 70 or higher on the VABS-II) (36 versus 39 percent, respectively; relative risk, 0.92; 95 percent confidence interval, 0.67 to 1.27; P = 0.63).

"Among comatose children who survived in-hospital cardiac arrest, therapeutic hypothermia, as compared with therapeutic normothermia, did not confer a significant benefit in survival with a favorable functional outcome at one year," the authors write.

Abstract
Full Text
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

FDA Approves First Generic Under-the-Tongue Suboxone

FDA Approves First Generic Under-the-Tongue Suboxone

May only be prescribed by Drug Addiction Treatment Act-certified prescribers

Kellogg's Honey Smacks Cereal Recalled Due to Salmonella Risk

Kellogg's Honey Smacks Cereal Recalled Due to <i>Salmonella</i> ...

Twenty-four people have been hospitalized, but no deaths have been reported

Portable Music Player Use Linked to Hearing Loss in Children

Portable Music Player Use Linked to Hearing Loss ...

Increased odds of high-frequency hearing loss with portable music player use

is free, fast, and customized just for you!




Already a member?

Sign In Now »